MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$19.02 -0.46 (-2.36%)
Open Price: 19.26
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients